Rituxirel 100 mg Injection
87.35$
65.82$
Rituxirel 100 mg injection is a powerful monoclonal antibody that plays a crucial role in managing various immune-related conditions, particularly certain types of cancer. Primarily, it is indicated for the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukemia, where it targets and helps eliminate malignant B cells. By binding to the CD20 protein on the surface of these cells, Rituxirel effectively disrupts their growth and survival, offering a targeted therapeutic approach. While this medication has shown significant benefits, it is important to be aware of potential side effects, such as infusion reactions and increased risk of infections, necessitating close monitoring by healthcare professionals. Patients should inform their doctor of any pre-existing conditions or concurrent medications to ensure safe use. With its well-established efficacy, Rituxirel serves as a vital option in oncology and immunotherapy, improving outcomes for many patients. For optimal results, it is typically administered under the supervision of a qualified healthcare provider. Always consult your physician for personalized advice and treatment plans tailored to your specific medical needs.
الكمية
Active Pharmaceutical Ingredient
Uses
• Rituxirel 100 mg injection is commonly used in the treatment of non-Hodgkin lymphoma (NHL). This type of cancer affects the lymphatic system and can be aggressive. Rituxirel works by targeting specific cells in the immune system to help reduce the cancerous growth. It is often administered as part of a comprehensive treatment plan.
• Another primary use of Rituxirel 100 mg injection is in managing rheumatoid arthritis. This chronic inflammatory condition affects the joints, leading to pain and disability. By targeting certain immune cells, Rituxirel helps to reduce inflammation and improve joint function. Patients may experience a significant reduction in symptoms with this therapy.
• Rituxirel 100 mg injection is also indicated for the treatment of chronic lymphocytic leukaemia (CLL). This blood cancer typically progresses slowly and affects the blood and bone marrow. Rituxirel aids in targeting and destroying the malignant B-cells responsible for CLL. It is often utilized in combination with other therapies for optimal effectiveness.
• Additionally, Rituxirel 100 mg injection is effective in treating granulomatosis with polyangiitis and microscopic polyangiitis. These are rare autoimmune conditions that cause inflammation of blood vessels. Rituxirel helps to decrease the abnormal immune response, leading to improved symptoms and better overall health. This medication plays a crucial role in managing these complex conditions.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Rituxirel 100 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician.
Rheumatoid arthritis: Rituximab Injection 100 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician.
Blood cancer (chronic lymphocytic leukemia): Leukemia, also known as blood cancer, is a malignant neoplasm of the hematopoietic tissues that impairs the body's ability to combat infection. Rituxirel 100 mg is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment.
Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Rituxirel 100 mg Vial is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA.
Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Rituxirel Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Anti-cancer Drug Rituxirel can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Rituxirel 100 mg is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Rituximab Injection 100 mg. Please consult your doctor.
• Kidney: Anti-cancer Drug Rituxirel is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Rituxirel Injection is likely to be safe to use while breastfeeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Rituxirel 100 mg Vial is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Rituxirel 100 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Rituximab Injection 100 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.